Market Cap

LIDDS AB Market Capitalization:

kr14.4 Million

SEK as of Jan. 1, 2024

US$1.4 Million

business LIDDS AB Company Profile

LIDDS AB Main Stock Listing

OMX: LIDDS

Market Capitalization History of LIDDS AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of LIDDS AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr14.4 M -74.22%
Jan. 1, 2023 kr55.8 M -84.04%
Jan. 1, 2022 kr350.0 M -34.30%
Jan. 1, 2021 kr532.7 M -25.94%
Jan. 1, 2020 kr719.2 M 25.08%
Jan. 1, 2019 kr575.0 M -13.33%
Jan. 1, 2018 kr663.5 M 150.00%
Jan. 1, 2017 kr265.4 M -14.49%
Jan. 1, 2016 kr310.3 M 3.66%
Jan. 1, 2015 kr299.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

LIDDS AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

LIDDS AB has the following listings and related stock indices.


Stock: OMX: LIDDS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.